Clearmind Medicine (CMND) Cash from Operations (2022 - 2026)
Clearmind Medicine (CMND) posted quarterly Cash from Operations of 1768080.0 for Q2 2026, down 60.97% year-over-year from 4529934.82 in Q2 2025, and up 15.2% quarter-over-quarter from 2084949.0 in Q1 2026.
Clearmind Medicine (CMND) Cash from Operations (2022 - 2026) Analysis & Trends
Clearmind Medicine's Cash from Operations history runs 5 years deep, the most recent figure standing at 1768080.0 for Q2 2026.
- In Q2 2026, Cash from Operations fell 60.97% year-over-year to 1768080.0; the TTM figure through Apr 2026 stood at 6223694.0 (down 36.25% YoY), while the FY2025 annual figure was 4734498.0, up 2.56% from the prior year.
- Cash from Operations for Q2 2026 stood at 1768080.0, up from 2084949.0 in the prior quarter.
- The five-year high for Cash from Operations was 3518601275506.0 in Q4 2022, with the low at 3518601743923.0 in Q3 2022.
- The 5-year median for Cash from Operations is 1265435.0 (2025), against an average of 1272225.67.
- Peak annual rise in Cash from Operations reached 100.0% in 2023, while the deepest fall reached 119.82% in 2023.
- Clearmind Medicine's Cash from Operations stood at 3518601275506.0 in 2022, then plunged by 100.0% to 753168.0 in 2023, then plunged by 43.02% to 1077145.0 in 2024, then fell by 19.37% to 1285827.0 in 2025, then tumbled by 37.51% to 1768080.0 in 2026.
- Business Quant data shows CMND's Cash from Operations at 1768080.0 in Q2 2026, 2084949.0 in Q1 2026, and 1285827.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.81 Bn | 130.96 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 86.07 Bn | 78.08 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 65.47 Bn | 60.29 Bn | 1.37 Bn | - |
| 4 | Moderna | 55.64 Bn | 50.50 Bn | 52.00 Mn | -526.00 Mn |
| 5 | BeOne Medicines | 41.99 Bn | 36.89 Bn | 1.53 Bn | 462.82 Mn |
| 6 | Alnylam Pharmaceuticals | 31.68 Bn | 28.37 Bn | 992.69 Mn | 326.72 Mn |
| 7 | BioNTech SE | 27.69 Bn | 9.29 Bn | 668.28 Mn | 360.27 Mn |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -88.83 Mn |
| 9 | Royalty Pharma | 27.36 Bn | 26.52 Bn | - | 728.46 Mn |
| 10 | Clearmind Medicine | 531,486.84 | -13.06 Mn | - | -1.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -1.77 Mn |
| Apr 30, 2026 | -1.77 Mn |
| Jan 31, 2026 | -2.08 Mn |
| Jan 31, 2026 | -2.08 Mn |
| Oct 31, 2025 | -1.29 Mn |
| Oct 31, 2025 | -1.29 Mn |
| Jul 31, 2025 | -1.08 Mn |
| Jul 31, 2025 | -1.08 Mn |
| Apr 30, 2025 | -1.10 Mn |
| Apr 30, 2025 | -1.10 Mn |
| Jan 31, 2025 | -1.27 Mn |
| Jan 31, 2025 | -1.27 Mn |
| Oct 31, 2024 | -1.08 Mn |
| Oct 31, 2024 | -1.08 Mn |
| Jul 31, 2024 | -1.13 Mn |
| Jul 31, 2024 | -1.13 Mn |
| Apr 30, 2024 | -1.19 Mn |
| Apr 30, 2024 | -1.19 Mn |
| Jan 31, 2024 | -1.46 Mn |
| Jan 31, 2024 | -1.46 Mn |